Related Experiment Video
Updated: Jun 14, 2026

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
Published on: January 8, 2017
Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy
1Department of Experimental Medicine and Cancer Research, Hebrew University Medical School, Jerusalem, Israel.
Abstract:
Fbw7 is a tumor suppressor that is mutated in numerous cancers. It encodes an E3 ubiquitin ligase, whose ability to decrease the levels of pivotal regulators of cell growth and proliferation underlies its tumor suppressor function. Here, we explore the consequences of Fbw7 inactivation on the outcome of chemotherapeutic treatments. When exposed to spindle toxins such as vinblastine and taxol, Fbw7-deficient cells undergo extensive mitotic slippage and endoreduplication, rendering them polyploid. A combined deregulation of several Fbw7 target proteins is required for this phenotype. Specifically, elevated expression of cyclin E and Aurora A in Fbw7-deficient cells is required for drug-induced polyploidy. However, overexpression of either cyclin E or Aurora A alone is not sufficient for drug-induced polyploidy. In addition, we demonstrate that Fbw7 deficiency limits the ability of p53 to respond to mitotic toxins but not to DNA damage. Furthermore, Fbw7 expression regulates the p53-dependent induction of genes such as Lats2 and p21 in response to vinblastine. Hence, we suggest that Fbw7 serves as a master regulator of the mitotic and tetraploidy checkpoints.
Insights
Fbw7, a tumor suppressor, regulates cell growth. Its inactivation leads to polyploidy and impaired p53 response to chemotherapy, affecting cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Fbw7 is a crucial tumor suppressor gene.
- It encodes an E3 ubiquitin ligase regulating cell growth and proliferation.
- Mutations in Fbw7 are linked to various cancers.
Purpose of the Study:
- To investigate the impact of Fbw7 inactivation on chemotherapy response.
- To understand the mechanisms behind Fbw7's role in cell cycle regulation and cancer.
Main Methods:
- Utilized Fbw7-deficient cell models.
- Exposed cells to spindle toxins (vinblastine, taxol).
- Analyzed cell ploidy, mitotic slippage, and protein expression levels (cyclin E, Aurora A, p53, Lats2, p21).
Main Results:
- Fbw7-deficient cells exhibited polyploidy due to mitotic slippage and endoreduplication when treated with spindle toxins.
- Combined elevation of cyclin E and Aurora A was necessary for this polyploidy.
- Fbw7 deficiency impaired p53's response to mitotic toxins but not DNA damage.
- Fbw7 regulated p53-dependent gene induction (Lats2, p21) following vinblastine treatment.
Conclusions:
- Fbw7 inactivation promotes drug-induced polyploidy by deregulating key cell cycle proteins.
- Fbw7 plays a critical role in p53-mediated responses to mitotic stress.
- Fbw7 acts as a master regulator of the mitotic and tetraploidy checkpoints, impacting cancer therapy effectiveness.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

